adesso SE

XTRA:ADN1 Voorraadrapport

Marktkapitalisatie: €388.3m

adesso Toekomstige groei

Future criteriumcontroles 4/6

adesso zal naar verwachting groeien in winst en omzet met respectievelijk 20.1% en 7.9% per jaar. De winst per aandeel zal naar verwachting groeien met 20% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 13.8% zijn.

Belangrijke informatie

20.1%

Groei van de winst

19.97%

Groei van de winst per aandeel

IT winstgroei13.1%
Inkomstengroei7.9%
Toekomstig rendement op eigen vermogen13.77%
Dekking van analisten

Good

Laatst bijgewerkt19 May 2026

Recente toekomstige groei-updates

Analyseartikel Nov 17

adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target

The investors in adesso SE 's ( ETR:ADN1 ) will be rubbing their hands together with glee today, after the share price...

Recent updates

Narratiefupdate May 23

ADN1: 2026 Guidance And Dividend Outlook Will Support Future Upside Potential

Analysts have trimmed their price target for adesso from about €107.67 to about €103.33, pointing to shifts in model assumptions around the discount rate, revenue growth, profit margins and future P/E as the key drivers behind the change. What's in the News adesso SE reaffirmed its earnings guidance for fiscal 2026, citing sustained demand for digitalisation projects despite the German government assessing weaker recovery trends for the German economy in 2026, particularly linked to energy prices (Corporate Guidance).
Narratiefupdate May 09

ADN1: 2026 Earnings Guidance And Dividend Policy Will Support Future Upside Potential

Analysts have reduced their price target on adesso from €114.17 to €107.67, citing slightly revised revenue growth and P/E assumptions along with a modestly higher profit margin outlook. What's in the News adesso reaffirmed earnings guidance for 2026, with expected revenues in a range of €1.6b to €1.7b and guidance that EBIT margin is expected to show only a little improvement in 2026 (Corporate Guidance).
Narratiefupdate Apr 24

ADN1: Higher Discount Rate Will Create Long Term Opportunity

Analysts have reduced their price target on adesso from €160 to €140, citing updated assumptions for a higher discount rate, slightly lower revenue growth and profit margin expectations, and a higher future P/E multiple. What's in the News adesso SE reaffirmed earnings guidance for 2026, with expected revenues in a range between €1.6b and €1.7b and only a little improvement in the EBIT margin in that year (Corporate Guidance).
Narratiefupdate Apr 10

ADN1: Dividend Visibility And Expanded Partnership Will Support Future Upside Potential

Analysts have trimmed their price target for adesso from about €127.83 to about €114.17. They now apply a higher discount rate, slightly lower revenue growth and profit margin assumptions, and a higher future P/E multiple in their models.
Analyseartikel Apr 07

Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality

When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...
Analyseartikel Feb 12

The Price Is Right For adesso SE (ETR:ADN1) Even After Diving 28%

The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 28%. Instead...
Analyseartikel Jan 22

adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel Oct 19

Is There Now An Opportunity In adesso SE (ETR:ADN1)?

adesso SE ( ETR:ADN1 ), is not the largest company out there, but it saw a significant share price rise of 23% in the...
Analyseartikel Sep 12

A Piece Of The Puzzle Missing From adesso SE's (ETR:ADN1) 32% Share Price Climb

adesso SE ( ETR:ADN1 ) shareholders would be excited to see that the share price has had a great month, posting a 32...
Analyseartikel Sep 10

Here's What's Concerning About adesso's (ETR:ADN1) Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analyseartikel May 25

Solid Earnings Reflect adesso's (ETR:ADN1) Strength As A Business

adesso SE's ( ETR:ADN1 ) earnings announcement last week was disappointing for investors, despite the decent profit...
Analyseartikel Feb 25

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.75

The board of adesso SE ( ETR:ADN1 ) has announced that the dividend on 6th of June will be increased to €0.75, which...
User avatar
Nieuw narratief Feb 07

Ongoing IT Investments Will Transform Operations By Mid-2025

Organic growth in healthcare and utilities drives future revenue, overcoming economic challenges, while strategic share buybacks reflect belief in undervaluation.
Analyseartikel Dec 02

Investors Still Aren't Entirely Convinced By adesso SE's (ETR:ADN1) Revenues Despite 32% Price Jump

adesso SE ( ETR:ADN1 ) shares have continued their recent momentum with a 32% gain in the last month alone. Not all...
Analyseartikel Nov 22

adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Investors signalled that they were pleased with adesso SE's ( ETR:ADN1 ) most recent earnings report. Looking deeper at...
Analyseartikel Nov 17

adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target

The investors in adesso SE 's ( ETR:ADN1 ) will be rubbing their hands together with glee today, after the share price...
Analyseartikel Nov 02

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyseartikel Aug 28

It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks

The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 25%. Instead...
Analyseartikel May 21

adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...
Analyseartikel Apr 19

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...
Analyseartikel Apr 18

Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analyseartikel Apr 02

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

The market for adesso SE's ( ETR:ADN1 ) shares didn't move much after it posted weak earnings recently. We did some...
Analyseartikel Mar 28

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Last week saw the newest full-year earnings release from adesso SE ( ETR:ADN1 ), an important milestone in the...
Analyseartikel Mar 23

Is adesso SE (ETR:ADN1) Trading At A 44% Discount?

Key Insights adesso's estimated fair value is €193 based on 2 Stage Free Cash Flow to Equity Current share price of...
Analyseartikel Mar 08

adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward

adesso SE ( ETR:ADN1 ) shares have had a really impressive month, gaining 29% after a shaky period beforehand. Not all...
Analyseartikel Dec 14

A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)

Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €95.16 With €91.00 share price...
Analyseartikel Oct 11

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel Jul 22

At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

adesso SE ( ETR:ADN1 ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Analyseartikel Jun 15

Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)

Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €146 With €123 share price...
Analyseartikel May 09

adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Analyseartikel Apr 22

What Does adesso SE's (ETR:ADN1) Share Price Indicate?

While adesso SE ( ETR:ADN1 ) might not be the most widely known stock at the moment, it saw significant share price...
Analyseartikel Feb 11

adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyseartikel Jan 26

Returns On Capital At adesso (ETR:ADN1) Have Stalled

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Winst- en omzetgroeiprognoses

XTRA:ADN1 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20281,94247701215
12/31/20271,80538541086
12/31/20261,6322742916
3/31/20261,537274183N/A
12/31/20251,489184386N/A
9/30/20251,42354787N/A
6/30/20251,37945493N/A
3/31/20251,335-15897N/A
12/31/20241,298381118N/A
9/30/20241,2695102135N/A
6/30/20241,225-194129N/A
3/31/20241,182-25183N/A
12/31/20231,14034377N/A
9/30/20231,0845-237N/A
6/30/20231,03712-28-1N/A
3/31/202396918735N/A
12/31/2022901291236N/A
9/30/2022836291236N/A
6/30/2022769281233N/A
3/31/2022725371736N/A
12/31/2021678483048N/A
9/30/2021636452343N/A
6/30/2021600462337N/A
3/31/2021564423447N/A
12/31/2020524215465N/A
9/30/2020503243440N/A
6/30/2020484193443N/A
3/31/2020467182233N/A
12/31/201945117N/A22N/A
9/30/201943215N/A13N/A
6/30/201941213N/A3N/A
3/31/201939513N/A10N/A
12/31/201837814N/A18N/A
9/30/201836414N/A22N/A
6/30/201835114N/A26N/A
3/31/201833613N/A23N/A
12/31/201732211N/A20N/A
9/30/201730711N/A17N/A
6/30/201729211N/A13N/A
3/31/201727612N/A14N/A
12/31/201626112N/A15N/A
9/30/201624510N/A14N/A
6/30/20162297N/A14N/A
3/31/20162136N/A15N/A
12/31/20151975N/A17N/A
9/30/20151834N/A17N/A
6/30/20151694N/A16N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei ADN1 ( 20.1% per jaar) ligt boven de spaarquote ( 1.9% ).

Winst versus markt: De winst van ADN1 ( 20.1% per jaar) zal naar verwachting sneller groeien dan de German markt ( 17.2% per jaar).

Hoge groeiwinsten: De winst van ADN1 zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van ADN1 ( 7.9% per jaar) zal naar verwachting sneller groeien dan de markt German ( 6.7% per jaar).

Hoge groei-inkomsten: De omzet van ADN1 ( 7.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen ADN1 zal naar verwachting over 3 jaar laag zijn ( 13.8 %).


Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/29 12:25
Aandelenkoers aan het einde van de dag2026/05/29 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

adesso SE wordt gevolgd door 11 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Daniel GroßjohannBankM AG
Wolfgang SpechtBerenberg
Finn KemperHauck Aufhäuser Investment Banking